Probiotec Limited provided earnings guidance for the year ending 30 June 2012. For the year, the company expects sales revenue in a range of $65.3 million - $66.6 million, EBITDA in a range of $7.6 million to $8.9 million and NPAT in a range of $1.4 million - $2.3 million.